Diclofenac sodium 1mg/g
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Sunburn
Conditions
Sunburn
Trial Timeline
Nov 1, 2006 → Dec 1, 2006
NCT ID
NCT00441051About Diclofenac sodium 1mg/g
Diclofenac sodium 1mg/g is a phase 3 stage product being developed by Novartis for Sunburn. The current trial status is completed. This product is registered under clinical trial identifier NCT00441051. Target conditions include Sunburn.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00441051 | Phase 3 | Completed |